LightNews LightNews
johnathansmid.bsky.social
@johnathansmid.bsky.social
8 followers 4 following 0 posts
Posts Replies Media Videos
Reposted
rudnicki-lab.bsky.social
An incredible achievement! 💊

www.businesswire.com/news/home/20...
Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a
www.businesswire.com
December 11, 2024 at 2:23 PM